|
|
Expression of serine protease 1 in gastric cancer and its influencing factors |
JIANG Qiang |
Tai′an Cancer Prevention and Treatment Hospital, Shandong Province, Tai′an 271000, China |
|
|
Abstract Objective To investigate the changes of serine protease 1 (HTRA1) in gastric cancer patients and the influencing factors.Methods A total of 220 patients with gastric cancer clinically diagnosed in our hospital from July 2016 to July 2019 were selected as study objects.The expression of HTRA1 in gastric cancer and distant cancer was detected by immunohistochemistry, and the relationship between HTRA1 expression and clinical characteristics of gastric cancer was analyzed.Results The positive expression rate of HTRA1 protein in gastric cancer tissues (13.18%) was lower than that in distant cancer tissues (86.82%), the difference was statistically significant (P>0.05).The differences in tumor diameter, invasion depth, smoking history, drinking history and mental state between positive and negative HTRA1 protein expression patients were statistically significant (P<0.05), while the difference in age, gender, tissue differentiation degree, lymph node metastasis and TNM stage between positive and negative HTRA1 protein expression patients were not statistically significant (P>0.05).Logistic regression analysis showed that tumor diameter (β=0.532,OR=1.873, 95%CI 0.372-2.711), invasion depth (β=0.837, OR=1.103, 95%CI 0.822-2.014), smoking history (β=0.486,OR=1.569, 95%CI 1.023-2.832), drinking history (β=0.590, OR=1.690, 95%CI 0.934-3.721) and mental state (β=0.829, OR=1.552, 95%CI 1.032-2.831) were independent risk factors affecting gastric cancer (P<0.05).Conclusion HRA1 protein expression in gastric cancer is related to tumor diameter, invasion depth, smoking history, drinking history and mental state.Tumor diameter, invasion depth, smoking history, drinking history and mental state are all risk factors affecting gastric cancer.
|
|
|
|
|
[1] |
Kwon D,Kim B,Shin HC,et al.Cancer panel assay for precision oncology clinic:results from a 1-year study[J].Transl Oncoil,2019,12(11):1488-1495.
|
[2] |
张刚,郭剑,李杰,等.P13K/AKT/mTOR 信号通路在胃癌组织中的表达及意义[J].广东医 学,2016,37(9):1330-1332.
|
[3] |
吴红学,童仕伦,柯东,等.胃癌组织中丝氨酸蛋白酶1 的表达及意义[J].山东医药,2018,58(25):57-59.
|
[4] |
Yang D,Kotzev AI,Draganov PV.Endoscopic submucosal dissection for early gastric cancer in the west:the absolute but not final word[J].Gastrointest Endosc,2019,90(3):480-482.
|
[5] |
岳佳伟,李大鹏,吴燕,等.椎间盘退变患者髓核组织中HtrA1 的表达及其与MMPs 的关系[J].山东医药,2017,57(22):83-85.
|
[6] |
陆林杰,卢怡.HTRA1 在中老年人牙周膜组织中的表达及对细胞增殖的作用[J].中国老年学杂志,2017,37(24):6031-6032.
|
[7] |
李冉,张旗.丝氨酸蛋白酶HtrA1 在人牙周膜组织中的表达及对人牙周膜细胞增殖的影响[J].中华口腔医学杂志,2016,51(2):87-92.
|
[8] |
Tan MC,Graham DY.Gastric cancer risk stratification and surveillance after Helicobacter pylori eradication:2020[J].Gastrointest Endosc,2019 ,90(3):457-460.
|
[9] |
余天,邢怡桥,陈长征.小干扰RNA 介导丝氨酸蛋白酶HtrA1 沉默对光损伤人视网膜色素上皮细胞的影响[J].中华眼底病杂志,2016,32(4):413-417.
|
[12] |
李彦,马欢,李媛,等.NF-κB 与IL-8 在幽门螺杆菌相关性胃癌组织中的表达及意义[J].实用医学杂志,2016,32(4):583-585.
|
[14] |
低氧诱导因子-1α 在胃癌组织中表达水平及分子作用机制研究[J].中国免疫学杂志,2017,33(12):1799-1803.
|
[10] |
Tazawa H,Suzuki T,Komo T,et al.A Case of advanced gastric cancer with peritoneal metastasis treated successfully with nivolumab[J].Case Rep Oncol,2019,12(2):523-528.
|
[11] |
Wu X,Wang H,Wu Y,et al.Efficacy of apatinib on multiple advanced-stage nongastric cancers[J].J Cancer Res Ther,2019,15(4):836-841.
|
[13] |
Gao S,Cao GH,Ding P,et al.Retrospective evaluation of lymphatic and blood vessel invasion and Borrmann types in advanced proximal gastric cancer[J].World J Gastrointest Oncol,2019,11(8):642-651.
|
[15] |
Basso V,Orry D,Fraisse J,et al.Safety and efficacy of a docetaxel-5FU-oxaliplatin regimen with or without trastuzumab in neoadjuvant treatment of localized gastric or gastroesophageal junction cancer:a retrospective study[J].World J Gastrointest Oncol,2019,11(8):634-641.
|
[16] |
Pan HM,Lang WY,Yao LJ,et al.shRNA-interfering LSD1 inhibits proliferation and invasion of gastric cancer cells via VEGF-C/PI3K/AKT signaling pathway[J].World J Gastrointest Oncol,2019,11(8):622-633.
|
[17] |
张立,张迪,周培华,等.NRP-1 在胃癌组织及细胞系中的表达及临床意义[J].西安交通大学学报(医学版),2016,37(1):82-86.
|
[18] |
柳麒,彭晋,江换钢,等.结合术前C反应蛋白/白蛋白比值建立预测cN0 胃癌患者淋巴结转移的列线图模型[J].中华肿瘤杂志,2019,41(8):599-603.
|
[19] |
王显艳,高峰,赵春明,等.miR-140 在人胃癌组织中的表达及对SGC-7901 胃癌细胞功能的影响[J].中国病理生理杂志,2016,32(4):651-657.
|
[20] |
Yang L,Yu Y,Zhang Q,et al.Anti-gastric cancer effect of Salidroside through elevating miR-99a expression[J].Artif Cells Nanomed Biotechnol,2019,47(1):3500-3510.
|
|
|
|